MedPath

Takeda Pharma A/S

🇩🇰Denmark
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.takeda.dk

Clinical Trials

14

Active:13
Completed:1

Trial Phases

2 Phases

Phase 1:2
Not Applicable:1

Drug Approvals

68

CIMA_AEMPS:35
NMPA:13
SFDA:11
+1 more agencies

Drug Approvals

Brentuximab Vedotin for Injection

Product Name
安适利
Approval Number
国药准字SJ20200008
Approval Date
Feb 7, 2025
NMPA

Vedolizumab for injection

Product Name
安吉优
Approval Number
国药准字SJ20200006
Approval Date
Nov 11, 2024
NMPA

Ixazomib Citrate Capsules

Product Name
恩莱瑞
Approval Number
国药准字HJ20180010
Approval Date
Feb 14, 2023
NMPA

Ixazomib Citrate Capsules

Product Name
恩莱瑞
Approval Number
国药准字HJ20180011
Approval Date
Feb 14, 2023
NMPA

Ixazomib Citrate Capsules

Product Name
恩莱瑞
Approval Number
国药准字HJ20180012
Approval Date
Feb 14, 2023
NMPA

Brigatinib Tablets

Product Name
安伯瑞
Approval Number
国药准字HJ20220019
Approval Date
Mar 22, 2022
NMPA

Brigatinib Tablets

Product Name
安伯瑞
Approval Number
国药准字HJ20220021
Approval Date
Mar 22, 2022
NMPA

Brigatinib Tablets

Product Name
安伯瑞
Approval Number
国药准字HJ20220020
Approval Date
Mar 22, 2022
NMPA

Azilsartan Medoxomil Potassium Tablets

Product Name
易达比
Approval Number
国药准字HJ20210003
Approval Date
Jan 19, 2021
NMPA

Azilsartan Medoxomil Potassium Tablets

Product Name
易达比
Approval Number
国药准字HJ20210004
Approval Date
Jan 19, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Not Applicable
1 (33.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.